Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) (Q28209814)
Jump to navigation
Jump to search
scientific article (publication date: 15 December 2002)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) |
scientific article (publication date: 15 December 2002) |
Statements
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) (English)
0 references
15 December 2002
0 references
100
0 references
13
0 references
4325-36
0 references